No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection.
作者信息
Molina J M, Delaugerre C, Le Goff J, Mela-Lima B, Ponscarme D, Goldwirt L, de Castro N
机构信息
Infectious Diseases Department, AP-HP-Saint-Louis Hospital, 1, avenue Claude-Vellefaux 75010 Paris, France; U944 INSERM, université de Paris, 75000 Paris, France.
Université de Paris, 75000 Paris, France; Virology Department, AP-HP-Saint-Louis Hospital, 75010 Paris, France.
出版信息
Med Mal Infect. 2020 Jun;50(4):384. doi: 10.1016/j.medmal.2020.03.006. Epub 2020 Mar 30.
Abstract
摘要
相似文献
1
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection.
Med Mal Infect. 2020 Jun;50(4):384. doi: 10.1016/j.medmal.2020.03.006. Epub 2020 Mar 30.
2
Audio Interview: Studying Potential Covid-19 Therapies.
N Engl J Med. 2020 May 7;382(19):e72. doi: 10.1056/NEJMe2015955.
3
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
Travel Med Infect Dis. 2020 May-Jun;35:101738. doi: 10.1016/j.tmaid.2020.101738. Epub 2020 May 5.
4
Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
Front Immunol. 2020 Aug 7;11:1969. doi: 10.3389/fimmu.2020.01969. eCollection 2020.
5
Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?
J Clin Pharmacol. 2020 Jul;60(7):808-814. doi: 10.1002/jcph.1646. Epub 2020 May 20.
6
Macrolides and viral infections: focus on azithromycin in COVID-19 pathology.
Int J Antimicrob Agents. 2020 Aug;56(2):106053. doi: 10.1016/j.ijantimicag.2020.106053. Epub 2020 Jun 10.
7
Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
Indian J Public Health. 2020 Jun;64(Supplement):S125-S127. doi: 10.4103/ijph.IJPH_496_20.
8
Acute meningoencephalitis in a patient with COVID-19.
Rev Neurol (Paris). 2020 Jun;176(6):519-521. doi: 10.1016/j.neurol.2020.04.014. Epub 2020 May 11.
9
Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan.
Trials. 2020 Oct 20;21(1):867. doi: 10.1186/s13063-020-04795-0.
10
Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome.
J Pharmacokinet Pharmacodyn. 2020 Jun;47(3):187-188. doi: 10.1007/s10928-020-09689-x. Epub 2020 May 13.
引用本文的文献
1
Emerging Treatment and Prevention Strategies against COVID-19: A Brief Update.
J Dig Endosc. 2020 Mar;11(1):69-72. doi: 10.1055/s-0040-1712547. Epub 2020 May 16.
2
Efficacy of Ivermectin, Chloroquine/Hydroxychloroquine, and Azithromycin in Managing COVID-19: A Systematic Review of Phase III Clinical Trials.
Biomedicines. 2024 Sep 27;12(10):2206. doi: 10.3390/biomedicines12102206.
3
The II Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19 Joint Guidelines of the Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia and Sociedade Brasileira de Reumatologia.
Crit Care Sci. 2023 Dec 22;35(3):243-255. doi: 10.5935/2965-2774.20230136-en. eCollection 2023.
4
Doxycycline vs Hydroxychloroquine + Azithromycin in the Management of COVID-19 Patients: An Open-Label Randomized Clinical Trial in Sub-Saharan Africa (DOXYCOV).
Cureus. 2023 Sep 20;15(9):e45619. doi: 10.7759/cureus.45619. eCollection 2023 Sep.
5
Impact of prophylactic hydroxychloroquine on ultrastructural impairment and cellular SARS-CoV-2 infection in different cells of bronchoalveolar lavage fluids of COVID-19 patients.
Sci Rep. 2023 Aug 5;13(1):12733. doi: 10.1038/s41598-023-39941-6.
6
COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery.
Genes Dis. 2023 Jul;10(4):1402-1428. doi: 10.1016/j.gendis.2022.12.019. Epub 2023 Apr 7.
7
Efficacy of plasmapheresis in neutropenic patients suffering from cytokine storm because of severe COVID-19 infection.
Blood Res. 2023 Jun 30;58(2):91-98. doi: 10.5045/br.2023.2022201. Epub 2023 May 10.
8
Discovery of Potential Inhibitors of SARS-CoV-2 Main Protease by a Transfer Learning Method.
Viruses. 2023 Mar 30;15(4):891. doi: 10.3390/v15040891.
9
Effect of an Immune-Boosting, Antioxidant and Anti-Inflammatory Food Supplement in Hospitalized COVID-19 Patients: A Prospective Randomized Pilot Study.
Nutrients. 2023 Apr 1;15(7):1736. doi: 10.3390/nu15071736.
10
Advances in natural product anti-coronavirus research (2002-2022).
Chin Med. 2023 Feb 13;18(1):13. doi: 10.1186/s13020-023-00715-x.
本文引用的文献
1
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
2
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
3
Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection.
Viruses. 2018 May 17;10(5):268. doi: 10.3390/v10050268.
4
Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases.
Pharmacol Res Perspect. 2017 Jan 23;5(1):e00293. doi: 10.1002/prp2.293. eCollection 2017 Feb.
5
Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial.
JAMA. 2012 Jul 25;308(4):353-61. doi: 10.1001/jama.2012.6936.
6
Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial.
Lancet Infect Dis. 2011 Sep;11(9):677-83. doi: 10.1016/S1473-3099(11)70065-2. Epub 2011 May 5.
7
A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults.
PLoS Negl Trop Dis. 2010 Aug 10;4(8):e785. doi: 10.1371/journal.pntd.0000785.
Zotero 插件